We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Tumors Avoid Destruction by Immune System

By LabMedica International staff writers
Posted on 19 Feb 2018
Print article
Image: A mouse tumor (grey/white areas) being infiltrated by cDC1 (yellow cells) that exited from blood vessels (blue). Red and green identify other immune cells. Infiltration by cDC1 triggers anti-cancer immune responses; this tumor will eventually be rejected by the mouse\'s immune system (Photo courtesy of Dr. Caetano Reis e Sousa, The Francis Crick Institute).
Image: A mouse tumor (grey/white areas) being infiltrated by cDC1 (yellow cells) that exited from blood vessels (blue). Red and green identify other immune cells. Infiltration by cDC1 triggers anti-cancer immune responses; this tumor will eventually be rejected by the mouse\'s immune system (Photo courtesy of Dr. Caetano Reis e Sousa, The Francis Crick Institute).
A molecular and pathway that aids tumors in avoiding destruction by the immune system was found to comprise natural killer cells, conventional type 1 dendritic cells, and prostaglandin E2.

Conventional type 1 dendritic cells (cDC1) are critical to a tumor's ability to avoid destruction by the immune system. In this regard, investigators at The Francis Crick Institute (London, United Kingdom) found that cDC1 accumulation in mouse tumors often depended on natural killer (NK) cells that produced the cDC1 chemoattractants CCL5 and XCL1. Similarly, in human cancers, CCL5, XCL1, and XCL2 transcripts within tumors were found to correlate closely with gene signatures of both NK cells and cDC1 and were associated with increased over all patient survival.

In a recent paper published in the February 8, 2018, online edition of the journal Cell, the investigators extended these findings by reporting that tumor-derived prostaglandin E2 (PGE2) impaired NK cell and cDC1 attraction, which resulted in improved ability of the cancer to avoid immune response.

"Our findings have given us a renewed appreciation of the importance of natural killer cells and cDC1 in the immune response against cancer," said senior author Dr. Caetano Reis e Sousa, Senior Group Leader at the Francis Crick Institute. "It is still early days, but attracting more cDC1 to tumors could be the basis of a new immunotherapy for cancer patients. Now that we know a bit better how this key anti-cancer response works, we can look at identifying other ways in which cancers get around it. This understanding will ultimately help us to develop new immunotherapy approaches to help more patients."

Related Links:
The Francis Crick Institute

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.